Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis

Ayman Sayyed, Hyewon Lee, Taehyung Simon Kim, Jaeyoon John Kim, Danielle Pyne, Nathali Kaushansky, Yardena Brilon, Noa Chapal-Ilani, Tamir Biezuner, Liran I. Shlush, Jan Storek, Dennis Dong Hwan Kim

Blood (2023) 142 (Supplement 1): 2207.

https://doi.org/10.1182/blood-2023-191191

Published: 2023

Journal Articles

The ELN 2022 Risk Stratification Has No Impact on the Dismal Prognosis of Patients with Acute Undifferentiated Leukemia

Baher Krayem, Tsila Zuckerman, Avraham Frisch, Ilana Slouzkey, Tehila Azoulay, Michal Karmona, Liran I. Shlush, Nathali Kaushansky, Noa Chapal-Ilani, Shimrit Ringelstein-Harlev

Blood (2023) 142 (Supplement 1): 4221.

https://doi.org/10.1182/blood-2023-188592

Published: 2023

Journal Articles

Unraveling at Diagnosis Chemoresistant Relapse-Initiating Clones in Acute Myeloid Leukemia: Combined Functional and Genomic Analyses Using Single-Cell-Derived Hematopoietic Stem and Progenitor Cell Subpopulations

Tsila Zuckerman, Tal Gabay, Nofar Stolero, Niv Rabhun, Rawan Sabah, Ofir Raz, Yaara Neumeier, Zipora Marx, Liming Tao, Tamir Biezuner, Shiran Amir, Rivka Adar, Ron Levy, Noa Chapal Ilani, Liran I. Shlush, Ehud Shapiro, Shlomit Yehudai-Reshef

Blood (2022) 140 (Supplement 1): 8584–8585.

https://doi.org/10.1182/blood-2022-165068

Published: 2022

Journal Articles

Fatty Bone Marrow Positively Selects Pre-Leukemic HSPCs with a DNMT3A- mutation

Naama Zioni, Noa Chapal Ilani, Ekaterina Petrovich-Kopitman, Mehmet Saçma, Hartmut Geiger, Marina Scheller, Carsten Mueller-Tidow, Nathali Kaushansky, Liran I. Shlush

Blood (2021) 138 (Supplement 1): 596.

https://doi.org/10.1182/blood-2021-149360

Published: 2021

Journal Articles

DNMT3A R882 Mutation in Human Haematopoietic Stem Cells Alters Differentiation Towards Neutrophils and Monocytes

Aditi Vedi, Daniel Hayler, Tamir Biezuner, Antonella Santoro, Kendig Sham, Amos Tuval, Adi Danin, Yoni Moskovitz, Liran I. Shlush, Elisa Laurenti

Blood (2021) 138 (Supplement 1): 2162.

https://doi.org/10.1182/blood-2021-150638

Published: 2021

Journal Articles

IPO11 Regulates the Nuclear Import of BZW1/2 and Is Necessary for AML Cells and Stem Cells

Boaz Nachmias, MDPhD, Veronique Voisin, PhD, Geethu Emily Thomas, PhDMSc,BSc, Dilshad H. Khan, Rose Hurren, BSc, Aaron Botham, Xiaoming Wang, Neil Maclean, Ayesh K Seneviratne, BSc, MSc, Changjiang Xu, Jonathan St-Germain, Andrea Arruda, MSc, Elias Orouji, Liran I. Shlush, MD, Mark D. Minden, Brian Raught, Gary D Bader, Aaron D Schimmer, MD PhD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-134787

Published: 2020

Journal Articles

Clonal hematopoiesis sees Twin Peaks

Liran I. Shlush

Blood (2020) 135 (4): 235–236.

https://doi.org/10.1182/blood.2019003869

Published: 2020

Journal Articles

Dasatinib Inhibits FLT3 /ITD and PTPN11 mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

Sigal Tavor, MD, Tali Shalit, PhD, Noa Chapal Ilani, PhD, Yoni Moskovitz, PhD, Nir Livnat, BSc, Yoram Groner, PhD, Haim Bar, PhD, Alexander Plotnikov, PhD, Nathali Kaushansky, PhD, Liran I. Shlush, MD

Blood (2019) 134 (Supplement_1): 1451.

https://doi.org/10.1182/blood-2019-128016

Published: 2019

Journal Articles

No Impact of Donor's Age-Related Clonal Hematopoiesis (ARCH) Observed on Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Result from Bar-Coded Error Corrected Sequencing in 33 Gene Mutations on 372 Pairs of Donor and Recipient

Kyoung Ha Kim, MD PhD, Taehyung Kim, MSc, Jae-Sook Ahn, MD PhD, Zeyad Al-Shaibani, Arjun Law, MD, Wilson Lam, MD, Fotios V. Michelis, MD PhD, Auro Viswabandya, MDDM, Jeffrey H. Lipton, MD PhD, Rajat Kumar, MD, Jonas Mattsson, MD, Zhaolei Zhang, PhD, Tamir Biezuner, PhD, Liran I. Shlush, MD, Dennis Dong Hwan Kim, MD PhD

Blood (2019) 134 (Supplement_1): 4514.

https://doi.org/10.1182/blood-2019-129497

Published: 2019

Journal Articles

IPO11 Is Upregulated in Relapsed AML and Supports Survival of Leukemic Stem Cells

Boaz Nachmias, MD PhD, Veronique Voisin, PhD, Rose Hurren, BSc, Xioaming Wang, Neil Maclean, G. Wei Xu, Ayesh K Seneviratne, BSc, MSc, Changjiang Xu, Gary D Bader, Liran I. Shlush, MD, Aaron D Schimmer, MD PhD

Blood (2019) 134 (Supplement_1): 2530.

https://doi.org/10.1182/blood-2019-122284

Published: 2019

Journal Articles

Donor Cell Leukemia: The Role of Recipient Microenvironment

Shlomit Yehudai-Reshef, PhD, Barak Oron, Yoni Moskovitz, PhD, Tal Gabay, Anna Fridman-Dror, Rawan Sabah, Nathali Kaushansky, PhD, Tsila Zuckerman, MD, Liran I. Shlush, MD PhD

Blood (2018) 132 (Supplement 1): 3853.

https://doi.org/10.1182/blood-2018-99-116145

Published: 2018

Journal Articles

Long Term AML Survivors Have Increased Mortality and High Prevalence of Clonal Hematopoiesis

Noa Chapal Ilani, PhD, Elisabeth Niemeyer, MD, Netta Mendelson Cohen, PhD, Yoni Moskovitz, PhD, Barak Oron, Amanda Mitchell, PhD, Mark D. Minden, MD PhD, Amos Tanay, PhD, Ran Balicer, MD PhD, Tamir Biezuner, PhD, Daniela Cilloni, MD PhD, Klaus H. Metzeler, MD, Yishai Ofran, MD, Nathali Kaushansky, PhD, Liran I. Shlush, MD PhD

Blood (2018) 132 (Supplement 1): 1287.

https://doi.org/10.1182/blood-2018-99-116599

Published: 2018

Journal Articles

Myelofibrosis Is Initiated and Sustained By Rare Multipotent Stem Cells

Jessie J.F. Medeiros, BSc, Amanda Mitchell, PhD, Aaron Trotman-Grant, Tristan Woo, Jenny M. Ho, MD, Andrea Arruda, Mark D. Minden, MD PhD, John E. Dick, PhD, Vikas Gupta, MD FRCP, FRCPath, Liran I. Shlush, MD PhD

Blood (2018) 132 (Supplement 1): 1790.

https://doi.org/10.1182/blood-2018-99-119088

Published: 2018

Journal Articles

Age-related clonal hematopoiesis

Liran I. Shlush

Blood (2018) 131 (5): 496–504.

https://doi.org/10.1182/blood-2017-07-746453

Published: 2018

Journal Articles

Progression to AML Is Predictable and Distinct from Age Related Clonal Hematopoiesis

Sagi Abelson, PhD, Stanley W.K. Ng, Omer Wiessbrod, Philip Zuzarte, Lawrence Heisler, Yogi Sundaravadanam, Ting Ting Wang, Trevor J. Pugh, PhD, David Soave, Paul Brennan, Mattias Johansson, Phillip Awadalla, Scott V. Bratman, Jean Wang, MD PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Liran I. Shlush

Blood (2017) 130 (Supplement 1): 471.

https://doi.org/10.1182/blood.V130.Suppl_1.471.471

Published: 2017

Journal Articles

CD200 Is a Marker of LSC Activity in Acute Myeloid Leukemia

Jenny M. Ho, MD, Stephanie M. Dobson, Jessica McLeod, Liqing Jin, MD PhD, Stanley W.K. Ng, MSc, Amanda Mitchell, PhD, Liran I. Shlush, MD PhD, Sasan Zandi, MD PhD, Kolja Eppert, PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Jean C.Y. Wang, MD PhD

Blood (2016) 128 (22): 1705.

https://doi.org/10.1182/blood.V128.22.1705.1705

Published: 2016

Journal Articles

Change comes like a little wind: tales in MDS evolution

Liran I. Shlush

Blood (2016) 128 (9): 1162–1163.

https://doi.org/10.1182/blood-2016-07-722660

Published: 2016

Journal Articles

On the Origins of AML Relapse

Liran I. Shlush, MDPhD, Amanda Mitchell, PhD, Lawrence Heisler, PhD, Sagi Abelson, PhD, Monica Doedens, McLeod Jessica, Ms.C., John D. McPherson, PhD, Thomas Hudson, MD PhD, Jean C.Y. Wang, MDPhD, Mark D. Minden, MD PhD, John E. Dick, PhD

Blood (2015) 126 (23): 223.

https://doi.org/10.1182/blood.V126.23.223.223

Published: 2015

Journal Articles

Engraftment Patterns in NOD. SCID Mice Predict Outcome in Human AML

James A. Kennedy, MDPhD, Amanda Mitchell, PhD, Weihsu Claire Chen, PhD, Liqing Jin, MD, Stanley Wai-Kwong Ng, BASc, Liran I. Shlush, MDPhD, Sasan Zandi, MDPhD, Jessica McLeod, BSc, Andreea C. Popescu, BSc, Nathan Mbong, BSc, Andrea Arruda, MSc, Mark D Minden, MDPhD, John E. Dick, PhD, Jean C.Y. Wang, MDPhD

Blood (2014) 124 (21): 16.

https://doi.org/10.1182/blood.V124.21.16.16

Published: 2014

Journal Articles

Functional and Phenotypic Characterization Of Acute Myeloid Leukemia By Analysis Of Diagnostic/Relapse Paired Samples

Jenny M. Ho, MD, Liran I. Shlush, MD, PhD, Amanda Mitchell, PhD, Rene Marke, Jessica McLeod, Mark D. Minden, MD PhD, John E. Dick, PhD, Jean C.Y. Wang, MD, PhD

Blood (2013) 122 (21): 2595.

https://doi.org/10.1182/blood.V122.21.2595.2595

Published: 2013

NARROW

The Presence of Somatic Mutation in Donor Does Not Affect Long-Term Outcomes in 339 Patients Following Allogeneic Hematopoietic Stem Cell Transplantation Using Uniform Fludarabine/Busulfan Myeloablative Conditioning and Cyclosporine/Methotrexate and ATG Gvhd Prophylaxis

The ELN 2022 Risk Stratification Has No Impact on the Dismal Prognosis of Patients with Acute Undifferentiated Leukemia

Unraveling at Diagnosis Chemoresistant Relapse-Initiating Clones in Acute Myeloid Leukemia: Combined Functional and Genomic Analyses Using Single-Cell-Derived Hematopoietic Stem and Progenitor Cell Subpopulations

Fatty Bone Marrow Positively Selects Pre-Leukemic HSPCs with a DNMT3A- mutation

DNMT3A R882 Mutation in Human Haematopoietic Stem Cells Alters Differentiation Towards Neutrophils and Monocytes

IPO11 Regulates the Nuclear Import of BZW1/2 and Is Necessary for AML Cells and Stem Cells

Clonal hematopoiesis sees Twin Peaks

Dasatinib Inhibits FLT3 /ITD and PTPN11 mutated Acute Myeloid Leukemia Cells Overexpressing SRC Tyrosine Kinases

No Impact of Donor's Age-Related Clonal Hematopoiesis (ARCH) Observed on Graft-Versus-Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation: Result from Bar-Coded Error Corrected Sequencing in 33 Gene Mutations on 372 Pairs of Donor and Recipient

IPO11 Is Upregulated in Relapsed AML and Supports Survival of Leukemic Stem Cells

Donor Cell Leukemia: The Role of Recipient Microenvironment

Long Term AML Survivors Have Increased Mortality and High Prevalence of Clonal Hematopoiesis

Myelofibrosis Is Initiated and Sustained By Rare Multipotent Stem Cells

Age-related clonal hematopoiesis

Progression to AML Is Predictable and Distinct from Age Related Clonal Hematopoiesis

CD200 Is a Marker of LSC Activity in Acute Myeloid Leukemia

Change comes like a little wind: tales in MDS evolution

On the Origins of AML Relapse

Engraftment Patterns in NOD. SCID Mice Predict Outcome in Human AML

Functional and Phenotypic Characterization Of Acute Myeloid Leukemia By Analysis Of Diagnostic/Relapse Paired Samples

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only